ArticleMedical science monitor : international medical journal of experimental and clinical research2017

Therapeutic Effect of Sodium Glucose Co-Transporter 2 Inhibitor Dapagliflozin on Renal Cell Carcinoma.

Haoyu Kuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.